These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38123228)

  • 1. Safety and efficacy of primaquine in patients with
    Verma R; Commons RJ; Gupta A; Rahi M; Nitika ; Bharti PK; Thriemer K; Rajasekhar M; Singh-Phulgenda S; Adhikari B; Alam MS; Ghimire P; Khan WA; Kumar R; Leslie T; Ley B; Llanos-Cuentas A; Pukrittayakamee S; Rijal KR; Rowland M; Saravu K; Simpson JA; Guerin PJ; Price RN; Sharma A
    BMJ Glob Health; 2023 Dec; 8(12):. PubMed ID: 38123228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial.
    Thriemer K; Degaga TS; Christian M; Alam MS; Rajasekhar M; Ley B; Hossain MS; Kibria MG; Tego TT; Abate DT; Weston S; Mnjala H; Rumaseb A; Satyagraha AW; Sadhewa A; Panggalo LV; Ekawati LL; Lee G; Anose RT; Kiros FG; Simpson JA; Karahalios A; Woyessa A; Baird JK; Sutanto I; Hailu A; Price RN
    Lancet; 2023 Dec; 402(10417):2101-2110. PubMed ID: 37979594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supervised versus unsupervised primaquine radical cure for the treatment of falciparum and vivax malaria in Papua, Indonesia: a cluster-randomised, controlled, open-label superiority trial.
    Poespoprodjo JR; Burdam FH; Candrawati F; Ley B; Meagher N; Kenangalem E; Indrawanti R; Trianty L; Thriemer K; Price DJ; Simpson JA; Price RN
    Lancet Infect Dis; 2022 Mar; 22(3):367-376. PubMed ID: 34710363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomised controlled trial to compare the efficacy, safety, and tolerability of low dose, short course primaquine in adults with uncomplicated P. vivax malaria in two hospitals in India.
    Ahmad SS; Verma R; Commons RJ; Nitika ; Singh-Phulgenda S; Chhajed R; Bharti PK; Behera B; Naser SM; Pal SK; Ranjit PH; Baharia RK; Solanki B; Upadhyay KJ; Guerin PJ; Sharma A; Price RN; Rahi M; Thriemer K
    Trials; 2024 Feb; 25(1):154. PubMed ID: 38424577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.
    Taylor WR; Hoglund RM; Peerawaranun P; Nguyen TN; Hien TT; Tarantola A; von Seidlein L; Tripura R; Peto TJ; Dondorp AM; Landier J; H Nosten F; Smithuis F; Phommasone K; Mayxay M; Kheang ST; Say C; Neeraj K; Rithea L; Dysoley L; Kheng S; Muth S; Roca-Feltrer A; Debackere M; Fairhurst RM; Song N; Buchy P; Menard D; White NJ; Tarning J; Mukaka M
    Malar J; 2021 Sep; 20(1):366. PubMed ID: 34503519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single low-dose tafenoquine combined with dihydroartemisinin-piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial.
    Stone W; Mahamar A; Smit MJ; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Keita S; Dicko OM; Diallo M; Maguiraga SO; Samake S; Attaher O; Lanke K; Ter Heine R; Bradley J; McCall MBB; Issiaka D; Traore SF; Bousema T; Drakeley C; Dicko A
    Lancet Microbe; 2022 May; 3(5):e336-e347. PubMed ID: 35544095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.
    Malla P; Wang Z; Brashear A; Yang Z; Lo E; Baird K; Wang C; Cui L
    J Infect Dis; 2024 May; 229(5):1557-1564. PubMed ID: 38041857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concizumab prophylaxis in people with haemophilia A or haemophilia B without inhibitors (explorer8): a prospective, multicentre, open-label, randomised, phase 3a trial.
    Chowdary P; Angchaisuksiri P; Apte S; Astermark J; Benson G; Chan AKC; Jiménez Yuste V; Matsushita T; Høgh Nielsen AR; Sathar J; Sutton C; Šaulytė Trakymienė S; Tran H; Villarreal Martinez L; Wheeler AP; Windyga J; Young G; Thaung Zaw JJ; Eichler H
    Lancet Haematol; 2024 Dec; 11(12):e891-e904. PubMed ID: 39521008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Azithromycin in severe malaria bacterial co-infection in African children (TABS-PKPD): a phase II randomised controlled trial.
    Connon R; Olupot-Olupot P; Pistorius AMA; Okiror W; Ssenyondo T; Muhindo R; Uyoga S; Mpoya A; Williams TN; Gibb DM; Walker AS; Ter Heine R; George EC; Maitland K
    BMC Med; 2024 Nov; 22(1):516. PubMed ID: 39506794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyronaridine-artesunate or dihydroartemisinin-piperaquine combined with single low-dose primaquine to prevent
    Stone W; Mahamar A; Sanogo K; Sinaba Y; Niambele SM; Sacko A; Keita S; Youssouf A; Diallo M; Soumare HM; Kaur H; Lanke K; Ter Heine R; Bradley J; Issiaka D; Diawara H; Traore SF; Bousema T; Drakeley C; Dicko A
    Lancet Microbe; 2022 Jan; 3(1):e41-e51. PubMed ID: 35028628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Global economic costs due to vivax malaria and the potential impact of its radical cure: A modelling study.
    Devine A; Battle KE; Meagher N; Howes RE; Dini S; Gething PW; Simpson JA; Price RN; Lubell Y
    PLoS Med; 2021 Jun; 18(6):e1003614. PubMed ID: 34061843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases.
    de Pina-Costa A; Silvino ACR; Dos Santos EM; Pedro RS; Moreira J; Umana GL; da Silva ADT; da Rosa Santos OHL; de Deus Henriques KM; Daniel-Ribeiro CT; Brasil P; Sousa TN; Siqueira AM
    Malar J; 2021 Aug; 20(1):341. PubMed ID: 34391426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.
    Pillay J; Gaudet LA; Saba S; Vandermeer B; Ashiq AR; Wingert A; Hartling L
    Syst Rev; 2024 Nov; 13(1):289. PubMed ID: 39593159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model.
    Price DJ; Nekkab N; Monteiro WM; Villela DAM; Simpson JA; Lacerda MVG; White MT; Devine A
    PLoS Med; 2024 Jan; 21(1):e1004255. PubMed ID: 38194420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transmission-blocking activity of antimalarials for Plasmodium vivax malaria in Anopheles darlingi.
    Andrade AO; Santos NAC; Bastos AS; Pontual JDC; Araújo JE; Silva AMV; Martinez LN; Lima AA; Aguiar ACC; G Teles CB; Medeiros JF; Pereira DB; Vinetz JM; Gazzinelli RT; Araújo MS
    PLoS Negl Trop Dis; 2023 Jun; 17(6):e0011425. PubMed ID: 37327209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring zinc deficiency using serum Zn levels: consequences and potential solutions in suckling pigs.
    Blavi L; Villagómez-Estrada S; Solà-Oriol D; Pérez JF
    J Anim Sci; 2024 Jan; 102():. PubMed ID: 38035764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for preventing weight gain after smoking cessation.
    Hartmann-Boyce J; Theodoulou A; Farley A; Hajek P; Lycett D; Jones LL; Kudlek L; Heath L; Hajizadeh A; Schenkels M; Aveyard P
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD006219. PubMed ID: 34611902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.
    Lim AWY; Schneider L; Loy C
    Cochrane Database Syst Rev; 2024 Nov; 11(11):CD001747. PubMed ID: 39498781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SEMAGLUTIDE: Weight loss, glycaemic control and safety profile in obese patients with and without type-II diabetes-An experience from Karachi, Pakistan.
    Memon MY; Ahsan T; Jabeen R; Latif S; Qasim SF; Imran P
    J Family Med Prim Care; 2024 Oct; 13(10):4188-4193. PubMed ID: 39629429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen for adults with hepatocellular carcinoma.
    Naing C; Ni H; Aung HH
    Cochrane Database Syst Rev; 2024 Aug; 8(8):CD014869. PubMed ID: 39132750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.